Who Paid My Doc
A Phase Iiib, Randomized, Multicenter, Parallel-Group, Non-Inferiority
Research payments
$151,947
Through program year 2022, $151,947 in research payments was reported against A Phase Iiib, Randomized, Multicenter, Parallel-Group, Non-Inferiority, across 27 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $151,947 | 27 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Chiu-Bin Hsiao Pittsburgh, PA Named on 2 payments
- William Towner Los Angeles, CA Named on 1 payment
- Gary Richmond Fort Lauderdale, FL Named on 1 payment
- Judith Aberg New York, NY Named on 1 payment
- Peter Ruane Los Angeles, CA Named on 1 payment
- Sara Bares Omaha, NE Named on 1 payment
- Princy Kumar Washington, DC Named on 1 payment
- Anthony Mills West Hollywood, CA Named on 1 payment
- Gordon Crofoot Houston, TX Named on 1 payment
- Mia Scott Denver, CO Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.